Exscientia (Exscientia) Cash-to-Debt : 9.32 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Exscientia Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Exscientia's cash to debt ratio for the quarter that ended in Mar. 2024 was 9.32.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Exscientia could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Exscientia's Cash-to-Debt or its related term are showing as below:

EXAI' s Cash-to-Debt Range Over the Past 10 Years
Min: 9.32 Med: 32.31 Max: 108.3
Current: 9.32

During the past 5 years, Exscientia's highest Cash to Debt Ratio was 108.30. The lowest was 9.32. And the median was 32.31.

EXAI's Cash-to-Debt is ranked better than
55.21% of 1527 companies
in the Biotechnology industry
Industry Median: 6.42 vs EXAI: 9.32

Exscientia Cash-to-Debt Historical Data

The historical data trend for Exscientia's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Exscientia Cash-to-Debt Chart

Exscientia Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

28.27

17.55

108.29

36.34

19.09

Exscientia Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial												22.92	21.32	20.03	19.09	9.32

Competitive Comparison of Exscientia's Cash-to-Debt

For the Biotechnology subindustry, Exscientia's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exscientia's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exscientia's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Exscientia's Cash-to-Debt falls into.

Exscientia Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Exscientia's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	457.157	/	(3.033	+	20.92)
	=	19.09

Exscientia's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	226.633	/	(3.375	+	20.954)
	=	9.32

Exscientia (NAS:EXAI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Exscientia Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Exscientia's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Exscientia (Exscientia) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exscientia PLC (NAS:EXAI) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

0RK:Germany 0RK:Germany

Address

Oxford Science Park, The Schrodinger Building, Oxford, GBR, OX4 4GE

Website

https://www.exscientia.ai

Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.